Produkty 84633-34-1

CAS 84633-34-1 występuje w naszej ofercie pod nazwami: Asparanin B, Shatavarin IV, 99.83%, Shatavarin IV, 98%, (2S,3R,4R,5R,6S)-2-(((2R,3S,4S,5R,6R)-4-Hydroxy-2-(hydroxymethyl)-6-(((2aR,4S,5'S,6aS,6bS,8aS,8bR,9S,10R,11aS,12aS,12bR)-5',6a,8a,9-tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-yl)oxy)-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol, 98%, Asparanin B, >=90% (LC/MS-ELSD). Oferty producentów: Biosynth, MedChemExpress, Ambeed, BLDpharm, Sigma-Aldrich. Dostępne opakowania: 2mg, 1mg, 5mg, 25mg, 10mg, 1 mg, 5 mg, 50mg.

Asparanin B
Biosynth
  • opakowanie: 2mg, 1mg, 5mg, 25mg
  • Warianty: 5
Zobacz produkt
Shatavarin IV, 99.83%
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 1536,42
Zobacz produkt
Shatavarin IV, 98%
Ambeed
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 5
od 1065,69
Zobacz produkt
(2S,3R,4R,5R,6S)-2-(((2R,3S,4S,5R,6R)-4-Hydroxy-2-(hydroxymethyl)-6-(((2aR,4S,5'S,6aS,6bS,8aS,8bR,9S,10R,11aS,12aS,12bR)-5',6a,8a,9-tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-yl)oxy)-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol, 98%
BLDpharm
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 5
od 1141,84
Zobacz produkt
Asparanin B, >=90% (LC/MS-ELSD)
Sigma-Aldrich
  • opakowanie: 1MG
  • Warianty: 1
od 1678,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-[(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S,16S,18R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol (CAS 84633-34-1) to związek chemiczny o wzorze sumarycznym C45H74O17 i masie molowej 887.1 g/mol. Nazwa systematyczna IUPAC: (2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-[(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S,16S,18R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol. InChIKey: BCUDKRWNGQAFLF-PJFZGHSASA-N.

Dane identyfikacyjne
Wzór sumarycznyC45H74O17
Masa molowa887.1 g/mol
Nazwa IUPAC(2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-[(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S,16S,18R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
InChIKeyBCUDKRWNGQAFLF-PJFZGHSASA-N
SMILESC[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)C)C)C)OC1

Dane obliczone przez PubChem (NCBI)

Synonimy: Shatavarin IV, Asparanin B, Curillin H, Sarsasapogenin 3-O-4G-rhamnosylsophoroside, Shatavarin IV(Asparanin B), orb1681699, orb3140681, Asparanin B, >=90% (LC/MS-ELSD), Asparanin B; Curillin H; Sarsasapogenin 3-O-4G-rhamnosylsophoroside